These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4849272

  • 1. [Observations on the prognosis of conservatively treated prostatic neoplasm].
    Hasselbacher K, Heinrichs H.
    Z Urol Nephrol; 1974 Mar; 67(3):161-4. PubMed ID: 4849272
    [No Abstract] [Full Text] [Related]

  • 2. Prognosis of prostatic cancer.
    Arvola I, Lilius HG, Uusi-Penttilä S.
    Ann Chir Gynaecol Fenn; 1972 Mar; 61(1):25-9. PubMed ID: 5021539
    [No Abstract] [Full Text] [Related]

  • 3. Cancer of the prostate.
    N Engl J Med; 1968 Apr 11; 278(15):848-9. PubMed ID: 5642506
    [No Abstract] [Full Text] [Related]

  • 4. Stilphostrol therapy in 100 cases of prostatic carcinoma.
    Rohlf PL, Flocks RH.
    J Iowa Med Soc; 1969 Dec 11; 59(12):1096-8. PubMed ID: 4187802
    [No Abstract] [Full Text] [Related]

  • 5. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF, Mellinger GT.
    J Urol; 1974 Jan 11; 111(1):58-64. PubMed ID: 4813554
    [No Abstract] [Full Text] [Related]

  • 6. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul 11; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
    Honda M, Takasaki E, Suzuki T, Maeda S, Imai T, Hosoya Y, Chen JA.
    Gan To Kagaku Ryoho; 1995 Jan 11; 22(1):105-9. PubMed ID: 7826063
    [Abstract] [Full Text] [Related]

  • 8. [Hormonal treatment of disseminated cancer of the prostate: results and survival obtained in a series of 60 patients].
    Izquierdo Font AJ, Barnadas Molins A, Germa Lluch JR, Marcuello Gaspar E, López López JJ.
    Actas Urol Esp; 1985 Jan 11; 9(3):231-6. PubMed ID: 4036688
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenocarcinoma of the prostate in men less than 56 years old: a study of 65 cases.
    Silber I, McGavran MH.
    J Urol; 1971 Feb 11; 105(2):283-5. PubMed ID: 5090372
    [No Abstract] [Full Text] [Related]

  • 11. Adenocarcinoma of the prostate gland.
    Finkelstein LH.
    J Am Osteopath Assoc; 1983 Apr 11; 82(8):543-6. PubMed ID: 6853232
    [No Abstract] [Full Text] [Related]

  • 12. Hormonal therapy: the benefits of postponed initiation.
    Cockburn AG.
    Urology; 1984 Nov 11; 24(5 Suppl):24-6. PubMed ID: 6388093
    [Abstract] [Full Text] [Related]

  • 13. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE, Welch MJ, Schmidt JD, Culp DA, Flocks RH.
    Urology; 1974 Oct 11; 4(4):431-4. PubMed ID: 4423432
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
    Germá Lluch JR, Marcuello Gaspar E, de Andrés Basauri L, López Pousa A, López López JJ.
    Rev Esp Oncol; 1982 Oct 11; 29(2):317-24. PubMed ID: 7188232
    [Abstract] [Full Text] [Related]

  • 15. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP, Slack NH.
    Urol Clin North Am; 1980 Oct 11; 7(3):631-8. PubMed ID: 6161459
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Ushiyama T, Ihara H, Kurita Y, Kageyama S, Ueda D, Mugiya S, Yamaguchi Y, Nakano M, Suzuki K, Kawabe K.
    Hinyokika Kiyo; 1993 Dec 11; 39(12):1139-44. PubMed ID: 8285162
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis].
    Ishibe T, Matsuki A, Nihira H.
    Hinyokika Kiyo; 1969 Mar 11; 15(3):195-205. PubMed ID: 5814574
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.